BSCL2-related neurologic disorders/seipinopathy

Endoplasmic reticulum stress in neurodegeneration

Daisuke Ito, Takuya Yagi, Norihiro Suzuki

Research output: Contribution to journalArticle

Abstract

The Seipin/BSCL2 gene was originally identified as a loss-of-function gene for congenital generalized lipodystrophy type 2, a condition characterized by severe lipoatrophy, insulin resistance, and hypertriglyceridemia. Whereas gain-of-toxic-function mutations (namely, mutations N88S and S90L) in the seipin gene have been identified in autosomal dominant motor neuron diseases such as Silver syndrome/spastic paraplegia 17 (SPG17) and distal hereditary motor neuropathy type V. Detailed phenotypic analyses have revealed that upper motor neurons, lower motor neurons and peripheral motor axons are variously affected in patients with these mutations. We recently showed that the N88S and S90L mutations disrupt the N-glycosylation motif, enhance ubiquitination, and appear to result in proteins that are improperly folded, leading to accumulation of the mutant protein in the endoplasmic reticulum (ER). We also showed that expression of mutant in cultured cells activates the UPR pathway and induces cell death, suggesting that seipinopathy is tightly associated with ER stress, which has recently been reported to be associated with other neurodegenerative diseases. Further study of the pathological mechanisms of the mutant forms of seipin may lead to important new insights into motor neuron diseases, including other spastic paraplegia diseases and amyotrophic lateral sclerosis.

Original languageEnglish
Pages (from-to)1186-1188
Number of pages3
JournalClinical Neurology
Volume51
Issue number11
DOIs
Publication statusPublished - 2011

Fingerprint

Endoplasmic Reticulum Stress
Nervous System Diseases
Motor Neuron Disease
Mutation
Motor Neurons
Congenital Generalized Lipodystrophy
Genes
Hypertriglyceridemia
Paraplegia
Poisons
Ubiquitination
Amyotrophic Lateral Sclerosis
Mutant Proteins
Glycosylation
Endoplasmic Reticulum
Neurodegenerative Diseases
Axons
Insulin Resistance
Cultured Cells
Cell Death

Keywords

  • Endoplasmic reticulum stress
  • Motor neuron disease
  • Seipin
  • Seipinopathy
  • SPG17

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

BSCL2-related neurologic disorders/seipinopathy : Endoplasmic reticulum stress in neurodegeneration. / Ito, Daisuke; Yagi, Takuya; Suzuki, Norihiro.

In: Clinical Neurology, Vol. 51, No. 11, 2011, p. 1186-1188.

Research output: Contribution to journalArticle

@article{ca264ff50c9d41c297bc279812628981,
title = "BSCL2-related neurologic disorders/seipinopathy: Endoplasmic reticulum stress in neurodegeneration",
abstract = "The Seipin/BSCL2 gene was originally identified as a loss-of-function gene for congenital generalized lipodystrophy type 2, a condition characterized by severe lipoatrophy, insulin resistance, and hypertriglyceridemia. Whereas gain-of-toxic-function mutations (namely, mutations N88S and S90L) in the seipin gene have been identified in autosomal dominant motor neuron diseases such as Silver syndrome/spastic paraplegia 17 (SPG17) and distal hereditary motor neuropathy type V. Detailed phenotypic analyses have revealed that upper motor neurons, lower motor neurons and peripheral motor axons are variously affected in patients with these mutations. We recently showed that the N88S and S90L mutations disrupt the N-glycosylation motif, enhance ubiquitination, and appear to result in proteins that are improperly folded, leading to accumulation of the mutant protein in the endoplasmic reticulum (ER). We also showed that expression of mutant in cultured cells activates the UPR pathway and induces cell death, suggesting that seipinopathy is tightly associated with ER stress, which has recently been reported to be associated with other neurodegenerative diseases. Further study of the pathological mechanisms of the mutant forms of seipin may lead to important new insights into motor neuron diseases, including other spastic paraplegia diseases and amyotrophic lateral sclerosis.",
keywords = "Endoplasmic reticulum stress, Motor neuron disease, Seipin, Seipinopathy, SPG17",
author = "Daisuke Ito and Takuya Yagi and Norihiro Suzuki",
year = "2011",
doi = "10.5692/clinicalneurol.51.1186",
language = "English",
volume = "51",
pages = "1186--1188",
journal = "Clinical Neurology",
issn = "0009-918X",
publisher = "Societas Neurologica Japonica",
number = "11",

}

TY - JOUR

T1 - BSCL2-related neurologic disorders/seipinopathy

T2 - Endoplasmic reticulum stress in neurodegeneration

AU - Ito, Daisuke

AU - Yagi, Takuya

AU - Suzuki, Norihiro

PY - 2011

Y1 - 2011

N2 - The Seipin/BSCL2 gene was originally identified as a loss-of-function gene for congenital generalized lipodystrophy type 2, a condition characterized by severe lipoatrophy, insulin resistance, and hypertriglyceridemia. Whereas gain-of-toxic-function mutations (namely, mutations N88S and S90L) in the seipin gene have been identified in autosomal dominant motor neuron diseases such as Silver syndrome/spastic paraplegia 17 (SPG17) and distal hereditary motor neuropathy type V. Detailed phenotypic analyses have revealed that upper motor neurons, lower motor neurons and peripheral motor axons are variously affected in patients with these mutations. We recently showed that the N88S and S90L mutations disrupt the N-glycosylation motif, enhance ubiquitination, and appear to result in proteins that are improperly folded, leading to accumulation of the mutant protein in the endoplasmic reticulum (ER). We also showed that expression of mutant in cultured cells activates the UPR pathway and induces cell death, suggesting that seipinopathy is tightly associated with ER stress, which has recently been reported to be associated with other neurodegenerative diseases. Further study of the pathological mechanisms of the mutant forms of seipin may lead to important new insights into motor neuron diseases, including other spastic paraplegia diseases and amyotrophic lateral sclerosis.

AB - The Seipin/BSCL2 gene was originally identified as a loss-of-function gene for congenital generalized lipodystrophy type 2, a condition characterized by severe lipoatrophy, insulin resistance, and hypertriglyceridemia. Whereas gain-of-toxic-function mutations (namely, mutations N88S and S90L) in the seipin gene have been identified in autosomal dominant motor neuron diseases such as Silver syndrome/spastic paraplegia 17 (SPG17) and distal hereditary motor neuropathy type V. Detailed phenotypic analyses have revealed that upper motor neurons, lower motor neurons and peripheral motor axons are variously affected in patients with these mutations. We recently showed that the N88S and S90L mutations disrupt the N-glycosylation motif, enhance ubiquitination, and appear to result in proteins that are improperly folded, leading to accumulation of the mutant protein in the endoplasmic reticulum (ER). We also showed that expression of mutant in cultured cells activates the UPR pathway and induces cell death, suggesting that seipinopathy is tightly associated with ER stress, which has recently been reported to be associated with other neurodegenerative diseases. Further study of the pathological mechanisms of the mutant forms of seipin may lead to important new insights into motor neuron diseases, including other spastic paraplegia diseases and amyotrophic lateral sclerosis.

KW - Endoplasmic reticulum stress

KW - Motor neuron disease

KW - Seipin

KW - Seipinopathy

KW - SPG17

UR - http://www.scopus.com/inward/record.url?scp=84856459709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856459709&partnerID=8YFLogxK

U2 - 10.5692/clinicalneurol.51.1186

DO - 10.5692/clinicalneurol.51.1186

M3 - Article

VL - 51

SP - 1186

EP - 1188

JO - Clinical Neurology

JF - Clinical Neurology

SN - 0009-918X

IS - 11

ER -